Correlation between Galectin-3 and Early Herpes Zoster Neuralgia and Postherpetic Neuralgia: A Retrospective Clinical Observation
Table 1
Comparison of general clinical data of patients.
Variable
Herpes zoster neuralgia (N = 40)
Neuralgia without HZV (N = 40)
F/χ2
PHN (N = 16)
Non-PHN (N = 24)
Age
69.25 ± 8.87 a
62.13 ± 8.73 b
61.60 ± 8.70 b
4.683
0.012
Sex
Male
6 (37.5) a
12 (50.0) a
19 (47.5) a
0.654
0.721
Female
10 (62.5) a
12 (50.0) a
21 (52.50) a
NRS score
5.75 ± 1.13 a
4.63 ± 0.58 b
4.90 ± 0.74 b
10.189
<0.001
The period of initial clinical visit
<1 d
2 (12.5) a
6 (25.0) a
9 (22.5) a
1.384
0.847
1∼3 d
7 (43.8) a
9 (37.5) a
18 (45.0) a
>3 d
7 (43.8) a
9 (37.5) a
13 (32.5) a
The surface area of skin
<3%
6 (37.5) a
7 (29.2) a
16 (40.0) a
1.612
0.807
3–5%
5 (31.3) a
10 (41.7) a
16 (40.0) a
>5%
5 (31.3) a
7 (29.2) a
8 (20.0) a
Combined disease
Yes
14 (87.5) a
19 (79.2) a
27 (67.5) a
2.756
0.252
No
2 (12.5) a
5 (20.8) a
13 (32.5) a
PHN, postherpetic neuralgia; HZV, herpes zoster virus; , value; N, number; NRS, numerical rating scale; d, day. Categorical variables are presented as numbers and percentages, while continuous variables are presented as mean ± standard deviation.
